Rescue therapy for acute migraine, part 3: Opioids, NSAIDs, steroids, and post-discharge medications

Headache

Volumn 52, Issue 3, 2012, Pages 467-482

  Kelley, Nancy E ^a   Tepper, Deborah E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

dihydroergotamine; emergency; magnesium; migraine; treatment; triptan

Indexed keywords

BUTORPHANOL; CHLORPROMAZINE; CLONIXIN LYSINE; DEXAMETHASONE; DICLOFENAC; DIHYDROERGOTAMINE; DIMENHYDRINATE; DIPHENHYDRAMINE; DIPYRONE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; HYDROXYZINE; IBUPROFEN; KETOROLAC; LEVOMEPROMAZINE; METOCLOPRAMIDE; NALBUPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PETHIDINE; PLACEBO; PREDNISONE; PROCHLORPERAZINE; PROMETHAZINE; SECOBARBITAL; STEROID; SUMATRIPTAN; TRAMADOL;

ABSENCE OF SIDE EFFECTS; AKATHISIA; ALLODYNIA; ANALGESIA; COMPARATIVE EFFECTIVENESS; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; EMERGENCY WARD; GASTROINTESTINAL SYMPTOM; HOSPITAL DISCHARGE; HOT FLUSH; HUMAN; INJECTION SITE BURNING; INJECTION SITE PAIN; MEDLINE; MIGRAINE; MIGRAINE WITHOUT AURA; NAUSEA; NAUSEA AND VOMITING; NOCICEPTION; PAIN ASSESSMENT; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SINGLE DRUG DOSE; STEROID THERAPY; SWELLING; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; MIGRAINE DISORDERS; PATIENT DISCHARGE; STEROIDS;

EID: 84858313941     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02097.x     Document Type: Review

References (48)

1. Friedman BW, Hochberg ML, Esses D, et al,. Recurrence of primary headache disorders after emergency department discharge: Frequency and predictors of poor pain and functional outcomes. Ann Emerg Med. 2008; 52: 696-704.
2. Tek D, Mellon M,. The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache. Ann Emerg Med. 1987; 16: 308-313. (Pubitemid 17025749)
3. Alemdar M, Pekdemir M, Selekler HM,. Single-dose intravenous tramadol for acute migraine pain in adults: A single-blind, prospective, randomized, placebo-controlled clinical trial. Clin Ther. 2007; 29: 1441-1447. (Pubitemid 47348115)
4. Bigal ME, Lipton RB,. Excessive acute migraine medication use and migraine progression. Neurology. 2008; 71: 1821-1828.
5. Klapper JA, Stanton JS,. Current emergency treatment of severe migraine headaches. Headache. 1993; 33: 560-562. (Pubitemid 23346606)
6. Carleton SC, Shesser RF, Pietrzak MP, et al,. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med. 1998; 32: 129-138. (Pubitemid 28355501)
7. Davis CP, Torrre PR, Williams C, et al,. Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: Evaluations by patients. Am J Emerg Med. 1995; 13: 146-150.
8. Duarte C, Dunaway F, Turner L, Aldag J, Frederick R,. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: A randomized, prospective, double-blind trial. Ann Emerg Med. 1992; 21: 1116-1121.
9. Harden RN, Gracely RH, Carter T, Warner G,. The placebo effect in acute headache management: Ketorolac, meperidine, and saline in the emergency department. Headache. 1996; 36: 352-356. (Pubitemid 26234956)
10. Lane PL, McLellan BA, Baggoley CJ,. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989; 18: 360-365. (Pubitemid 19103771)
11. Larkin GL, Prescott JE,. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med. 1992; 21: 919-924.
12. Richman PB, Allegra J, Eskin B, et al,. A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache. Am J Emerg Med. 2002; 20: 39-42. (Pubitemid 34052515)
13. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E,. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989; 39: 590-592. (Pubitemid 19105782)
14. Scherl ER, Wilson JF,. Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995; 35: 256-259.
15. Stiell IG, Dufour DG, Moher D, Yen M, Beilby WJ, Smith NA,. Methotrimeprazine versus meperidine and dimenhydrinate in the treatment of severe migraine: A randomized, controlled trial. Ann Emerg Med. 1991; 20: 1201-1205.
16. Engindeniz Z, Demircan C, Karli N, et al,. Intramuscular tramadol vs. diclofenac sodium for the treatment of acute migraine attacks in emergency department: A prospective, randomized, double-blind study. J Headache Pain. 2005; 6: 143-148. (Pubitemid 40916529)
17. Cicek M, Karcioglu O, Parlak I, et al,. Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emerg Med J. 2004; 21: 323-326. (Pubitemid 38590616)
18. Watkins LR, Milligan ED, Maier SF,. Glial activation: A driving force for pathological pain. Trends Neurosci. 2001; 24: 450-455. (Pubitemid 32695356)
19. Seim MB, March JA, Dunn KA,. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1998; 5: 573-576. (Pubitemid 28283652)
20. Meredith JT, Wait S, Brewer KL,. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003; 21: 173-175. (Pubitemid 36734676)
21. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R,. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005; 45: 850-861. (Pubitemid 41045361)
22. Klapper JA, Stanton JS,. Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches. Headache. 1991b; 31: 523-524.
23. Bigal ME, Bordini CA, Speciali JG,. Intravenous metamizole (Dipyrone) in acute migraine treatment and in episodic tension-type headache-a placebo-controlled study. Cephalalgia. 2001; 21: 90-95. (Pubitemid 32575470)
24. Krymchantowski AV, Carneiro H, Barbosa J, Jevoux C,. Lysine clonixinate versus dipyrone (metamizole) for the acute treatment of severe migraine attacks: A single-blind, randomized study. Arq Neuropsiquiatr. 2008; 66: 216-220. (Pubitemid 351883905)
25. Ellis GL, Delaney J, DeHart DA, Owens A,. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993; 22: 191-195. (Pubitemid 23058897)
26. Ducharme J, Beveridge RC, Lee JS, Beaulieu S,. Emergency management of migraine: Is the headache really over? Acad Emerg Med. 1998; 5: 899-905. (Pubitemid 28409437)
27. Innes GD, Macphail I, Dillon EC, Metcalfe C, Gao M,. Dexamethasone prevents relapse after emergency department treatment of acute migraine: A randomized clinical trial. CJEM. 1999; 1: 26-33.
28. Klapper JA, Stanton JS,. The emergency treatment of acute migraine headache; a comparison of intravenous dihydroergotamine, dexamethasone, and placebo. Cephalalgia. 1991a; 11 (Suppl. 11): 159-160.
29. Baden EY, Hunter CJ,. Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: A randomized, double-blind, placebo-controlled clinical trial. CJEM. 2006; 8: 393-400. (Pubitemid 44768710)
30. Friedman BW, Greenwald P, Bania TC, et al,. Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology. 2007; 69: 2038-2044. (Pubitemid 350175705)
31. Rowe BH, Colman I, Edmonds ML, Blitz S, Walker A, Wiens S,. Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache. 2008; 48: 333-340. (Pubitemid 351517786)
32. Donaldson D, Sundermann R, Jackson R, Bastani A,. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: A multicenter, double-blinded, placebo-controlled randomized clinical trial. Am J Emerg Med. 2008; 26: 124-130. (Pubitemid 351215765)
33. Feisseler FW, Shih R, Szucs P, et al,. Steroids for migraine headaches: A randomized double-blind two-armed, placebo-controlled trial. J Emerg Med. 2011; 40: 463-468.
34. Trainor A, Miner J,. Pain treatment and relief among patients with primary headache subtypes in the ED. Am J Emerg Med. 2008; 26: 1029-1034.
35. Wasay M, Zaki KS, Khan SU, Rehmani R,. Narcotic analgesics for acute migraine in the emergency room: Are we meeting Headache Societies' guidelines? J Headache Pain. 2006; 7: 413-415. (Pubitemid 46085246)
36. Blumenthal HJ, Weisz MA, Kelly KM, Mayer RL, Blonsky J,. Treatment of primary headache in the emergency department. Headache. 2003; 43: 1026-1031. (Pubitemid 37543068)
37. Akpunonu BE, Mutgi AB, Federman DJ, et al,. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: A multicenter study. Ann Emerg Med. 1995; 25: 464-469.
38. Friedman BW, Solorzano C, Esses D, et al,. Treating headache recurrence after emergency department discharge: A randomized controlled trial of naproxen versus sumatriptan. Ann Emerg Med. 2010; 56: 7-17.
39. Gerhardt RT, Hermstad E, Crawford DM, Rayfield J, Pfaff J, Hunter CJ,. Postdischarge secobarbital after ED migraine treatment decreases pain and improves resolution. Am J Emerg Med. 2011; 29: 86-90.
40. Ho TW, Rodgers A, Bigal ME,. Impact of recent prior opioid use of rizatriptan efficacy. Headache. 2009; 49: 395-403.
41. Langemark M, Olesan J,. Drug abuse in migraine patients. Pain. 1984; 19: 81-86. (Pubitemid 14145266)
42. Salomone JA 3rd, Thomas RW, Althoff JR, Watson WA,. An evaluation of the role of the ED in the management of migraine headaches. Am J Emerg Med. 1994; 12: 134-137. (Pubitemid 24112538)
43. Hussain W, Young WB,. Steroids and aseptic osteonecrosis (AON) in migraine patients. Headache. 2007; 47: 600-604. (Pubitemid 46625252)
44. Kelley NE, Tepper DE,. Rescue therapy for acute migraine, Part 1: Triptans, dihydroergotamine, and magnesium. Headache. 2012; 52: 114-128.
45. Kelley NE, Tepper DE,. Rescue therapy for acute migraine, Part 2: Neuroleptics, antihistamines, and others. Headache. 2012; 52: 292-306.
46. Sheftell F, O'Quinn S, Watson C, Pait D, Winter P,. Low migraine headache recurrence with naratriptan: Clinical parameters related to recurrence. Headache. 2000; 40: 103-110. (Pubitemid 30132050)
47. Colman I, Rothney A, Wright SC, Zilkalns B, Rowe BH,. Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology. 2004; 62: 1695-1700. (Pubitemid 38661721)
48. Tornabene SV, Deutsch R, Davis DP, Chan TC, Vilke GM,. Evaluating the use and timing of opioids for the treatment of migraine headaches in the emergency department. J Emerg Med. 2009; 36: 333-337.